BrainEver and 3P Biopharmaceuticals developing drug with hopes to cure ALS
3P BioPharmaceuticals and BrainEver are to collaborate on developing hEng1, a recombinant homeoprotein, to treat…
November 15, 2022 - 2 minutes
Parkinson’s
Funding for NRG Therapeutics to work on mitochondria link to Parkinson’s and ALS
NRG Therapeutics, Ltd. has closed a £16 million ($18.2 million) series A financing. The funding…
November 10, 2022 - 3 minutes
Muna Therapeutics gets $4.9M grant for Parkinson’s disease research
Muna Therapeutics has been awarded a $4.9 million grant from The Michael J. Fox Foundation…
October 11, 2022 - 3 minutes
Neuron23 and QIAGEN to collaborate on diagnostic for novel Parkinson’s drug
Neuron23 Inc. and QIAGEN are to collaborate to develop a companion diagnostic for Neuron23's LRRK2…
September 15, 2022 - 3 minutes
Collaboration to explore gene therapy products for neurodegenerative disorders
Coave Therapeutics is collaborating with the Institute of Neurodegenerative Diseases (IMN) of Bordeaux to develop…
September 14, 2022 - 3 minutes
IRLAB’s partner Ipsen starts mesdopetam clinical studies
IRLAB Therapeutics AB, a clinical-stage biopharmaceutical company discovering and developing novel treatments for the most…
September 6, 2022 - 3 minutes
Parkinson’s Foundation and Parkinson’s UK partner to drive drug development
The Parkinson's Foundation and Parkinson's UK, which funds research and provides support for people with…
August 23, 2022 - 3 minutes
NRG Therapeutics selects Domainex for project aimed at finding candidate for neurogenerative disorders
A neuroscience company targeting mitochondrial dysfunction has teamed up with an organization developing small molecule…
June 30, 2022 - 3 minutes
Expansion into Europe for BlueRock Therapeutics
BlueRock Therapeutics LP, a clinical stage biopharmaceutical company and wholly-owned subsidiary of Bayer AG, has…
June 10, 2022 - 2 minutes
Award to help NRG Therapeutics develop new Parkinson’s and Motor Neuron Disease treatments
UK neuroscience company NRG Therapeutics Ltd has received a Biomedical Catalyst (BMC) award to fund…
May 31, 2022 - 3 minutes
Sponsored
by WuXi AppTec
Discovering New Therapeutic Targets for Alzheimer’s Disease
Effective therapies for neurodegenerative diseases like Alzheimer’s are urgently needed. But developing new drugs is…
September 22, 2021 - 7 minutes
European Biotechs Fire up Deals to Develop Parkinson’s Treatments
Last month, European biotechs Ipsen and AC Immune announced multi-million euro deals to acquire or…
August 12, 2021 - 4 minutes
